Kura Oncology Inc (KURA) Rapporto sugli Utili - Previsioni e Surprise Ratio

Pubblicita'

Storico dei ricavi trimestrali

KURA rapporto: 65%

100%

KURA supera 22 di 34 ultime stime

Data del prossimo reportNov 7, 2024

Stimato per Q3 24:$-0.66

Cambiamenti implicati per il Q2 24:+11.86%

Cambiamenti implicati per il Q3 23:+32.00%

Periodo Bilanci	Data Riportata	EPS / Previsioni	Sorpresa
Q2 24	Aug 8, 2024	$-0.59 / $-0.63	$0.04 / 6.35%
Q1 24	May 2, 2024	$-0.59 / $-0.56	$-0.03 / -5.36%
Q4 23	Feb 27, 2024	$-0.55 / $-0.56	$0.01 / 1.79%
Q3 23	Nov 2, 2023	$-0.5 / $-0.56	$0.06 / 10.71%
Q2 23	Aug 3, 2023	$-0.53 / $-0.57	$0.04 / 7.02%
Q1 23	May 10, 2023	$-0.5 / $-0.54	$0.04 / 7.41%
Q4 22	Feb 23, 2023	$-0.49 / $-0.58	$0.09 / 15.52%
Q3 22	Nov 3, 2022	$-0.53 / $-0.57	$0.04 / 7.02%

Fornitori di Dati: Xignite Logo